Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com
Mobile Text Messages Improve Diabetes, Heart Risk Control

September 2nd 2025

Weekly mobile messages improved blood sugar, blood pressure, and heart health risk management in patients with type 2 diabetes (T2D), a study finds.

CGM-habrovich-stock.adobe.com
Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes

August 27th 2025

Woman with vision problem | Image credit: Jo Panuwat D - stock.adobe.com
Gaps Exist in Diabetic Retinopathy Screening Knowledge Among Providers, Study Finds

August 26th 2025

heart - inthasone - stock.adobe.com
METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes

August 22nd 2025

eye health in a clinical setting-Microgen-stock.adobe.com
Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk

August 18th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background
Continuing Medical Education
View All
September 4th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 4th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

This Week in Managed Care: September 6, 2019
September 6th 2019

This Week in Managed Care: September 6, 2019

This week, the top managed care news included a diabetes drug showing positive results in treating heart failure; new lipid guidelines promoting the use of proprotein convertase subtilisin/kexin type 9 inhibitors; and a study finding doctors are more likely to prescribe opioids if they are in a hurry.
What We're Reading: NYC Measles Outbreak Ends; Addressing Medical Debt; Betting on a T1D Cure
September 4th 2019

What We're Reading: NYC Measles Outbreak Ends; Addressing Medical Debt; Betting on a T1D Cure

AJMC Staff
New York City health officials have declared an end to the city’s biggest measles outbreak in nearly 3 decades; Senator Bernie Sanders, I-Vermont, has proposed canceling $81 billion in existing medical debt; Vertex Pharmaceuticals is taking a chance on a start-up’s early-stage science that could potentially one day emerge as a functional cure for type 1 diabetes (T1D).
Patients With CAD, Diabetes, Prior PCI See Most Benefit From Ticagrelor in THEMIS
September 1st 2019

Patients With CAD, Diabetes, Prior PCI See Most Benefit From Ticagrelor in THEMIS

Matthew Gavidia
Coverage from the European Society of Cardiology 2019 Congress in Paris, France.
Site Logo
August 28th 2019

Keeping Glucose in Range, With the Right Tools and Treatment for Management

Mary Caffrey
Coverage from the July 11, 2019, meeting of the Institute for Value-Based Medicine®, an initiative of The American Journal of Managed Care®. The meeting took place in Arlington, Virginia.
FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure
August 27th 2019

FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure

Matthew Gavidia
Dapagliflozin’s fast track designation follows findings from last year’s DECLARE-TIMI trial, a cardiovascular outcomes trial that showed the drug’s significant impact on delaying the loss of kidney function and reducing hospitalization risk for heart failure.
City of Hope Scientist Explores Genomic Instability as the Key Link Between Diabetes and Cancer
August 26th 2019

City of Hope Scientist Explores Genomic Instability as the Key Link Between Diabetes and Cancer

Mary Caffrey
The findings suggest that a commonly used diabetes therapy, metformin, could be used to target specific proteins that trigger DNA repair.
Childhood Cancer Survivors Have a Heightened Risk of Heart Disease, Study Shows
August 26th 2019

Childhood Cancer Survivors Have a Heightened Risk of Heart Disease, Study Shows

Matthew Gavidia
Cancer treatment raises the risk of heart disease in childhood cancer survivors, as does diabetes and hypertension.
5 Things to Look for at the European Society of Cardiology 2019 Congress
August 23rd 2019

5 Things to Look for at the European Society of Cardiology 2019 Congress

Mary Caffrey
Studies on anticoagulants and SGLT2 inhibitors, and guidelines for dyslipidemia and more are anticipated at the meeting.
Older Women With Diabetes Have an Increased Risk for Sleep Problems, Study Finds
August 19th 2019

Older Women With Diabetes Have an Increased Risk for Sleep Problems, Study Finds

Matthew Gavidia
During the menopause transition, women with type 2 diabetes are more likely to have sleep disturbances due to an alteration in their hormonal response to insulin.
Unmet Care Targets Suggest Need for Improved Diabetes Care Accessibility
August 18th 2019

Unmet Care Targets Suggest Need for Improved Diabetes Care Accessibility

Alison Rodriguez
Despite advances in therapies for diabetes, those living with the disease are not faring better in reaching treatment targets due to lack of access to care, starting with the ability to be properly diagnosed.
A Discussion on Managing and Treating Type 2 Diabetes
August 6th 2019

A Discussion on Managing and Treating Type 2 Diabetes

As a progressive condition, diabetes presents an ongoing challenge for physicians to provide adequate control of patients’ disease, and new agents with novel mechanisms of action help reduce the burden in the management of diabetes.
This Week in Managed Care: August 2, 2019
August 2nd 2019

This Week in Managed Care: August 2, 2019

This week, the top managed care news included HHS laying out a plan for importing certain prescription drugs from other countries; a potential new standard of care for chronic lymphocytic leukemia; 3 insulin makers get subpoenaed over their pricing practices.
Top 5 AJMC® Articles of July 2019
July 31st 2019

Top 5 AJMC® Articles of July 2019

Here are the top 5 articles for the month of July.
What We're Reading: Democrats Debate Medicare for All; Insulin Makers Questioned; Best Hospital Rankings
July 31st 2019

What We're Reading: Democrats Debate Medicare for All; Insulin Makers Questioned; Best Hospital Rankings

AJMC Staff
Tuesday's Democratic presidential debate, the first of 2 days, included disagreements over the viability of Medicare for All; 3 insulin makers received subpoenas from the New York Attorney General over their pricing practices; US News & Report released its 30th Annual Best Hospitals rankings.
V-BID X: A Template for Aligning Cost Sharing With Value of Services
July 30th 2019

V-BID X: A Template for Aligning Cost Sharing With Value of Services

Jaime Rosenberg
The University of Michigan Center for Value-Based Insurance Design (V-BID), in collaboration with a group of healthcare stakeholders, has announced the details of V-BID X, a template for reducing cost sharing for certain high-value services and raising cost sharing for certain low-value services while not increasing premiums or deductibles.
FDA Approves Eli Lilly's Nasal Glucagon to Treat Severe Hypoglycemia Without Injection
July 25th 2019

FDA Approves Eli Lilly's Nasal Glucagon to Treat Severe Hypoglycemia Without Injection

Allison Inserro
Nasal glucagon is seen as a game-changing delivery method to replace the multistep system of mixing powder and liquid with a simple, 1-step spray.
Bipartisan Senate Bill Seeks to Roll Back a Decade's Worth of Insulin Price Hikes
July 23rd 2019

Bipartisan Senate Bill Seeks to Roll Back a Decade's Worth of Insulin Price Hikes

Mary Caffrey
The bill would reduce prices up to 75% based on anticipated 2020 levels, according to Senator Jeanne Shaheen, D-NH, the lead sponsor.
New Guidance Allows HDHPs to Expand Preventive Care Benefits for Chronic Conditions
July 19th 2019

New Guidance Allows HDHPs to Expand Preventive Care Benefits for Chronic Conditions

Jaime Rosenberg
Under new guidance released by Internal Revenue Service and the Department of Treasury, high-deductible health plans (HDHPs) with health savings accounts can cover chronic care treatment before a patient meets their deductible.
What We're Reading: Alzheimer Blood Test; Planned Parenthood Ousts President; Glucose Monitor Production
July 17th 2019

What We're Reading: Alzheimer Blood Test; Planned Parenthood Ousts President; Glucose Monitor Production

AJMC Staff
Researchers are closing in on a sought after goal of a blood test that can detect posssible signs of Alzheimer disease and other forms of dementia; Planned Parenthood President Leana Wen, MD, has been ousted after 8 months; Abbott Laboratories is ramping up manufacturing capacity for its lower-cost continuing glucose monitor FreeStyle Libre.
Podcast: This Week in Managed Care—ACA Individual Mandate Uncertainty and Other Health News
July 14th 2019

Podcast: This Week in Managed Care—ACA Individual Mandate Uncertainty and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Exercise Intervention May Reduce Risk of Metabolic Diseases and Improve Work Productivity
July 12th 2019

Exercise Intervention May Reduce Risk of Metabolic Diseases and Improve Work Productivity

Alison Rodriguez
An exercise-focused intervention may be effective for improving mental health, work ability, and productivity outcomes while reducing metabolic syndrome severity for individuals at a high risk for cardiovascular and metabolic disease, according to researchers.
This Week in Managed Care: July 12, 2019
July 12th 2019

This Week in Managed Care: July 12, 2019

This week, the top managed care news included uncertainty surrounding the fate of the Affordable Care Act's individual mandate; a study finding Medicare beneficiaries may be paying more for some generics than brand-name drugs; the Trump administration proposing 5 new payment models to transform kidney disease care.
What We're Reading: Improving Federal Quality Programs; T1D Funding; Polio-Like Illness Confirmed
July 11th 2019

What We're Reading: Improving Federal Quality Programs; T1D Funding; Polio-Like Illness Confirmed

AJMC Staff
HHS has launched a summit to streamline and improve quality programs across the agency; more than 160 children with type 1 diabetes (T1D) appeared before a Senate committee to ask for more funding for the Special Diabetes Program; the CDC has confirmed 11 cases of a rare polio-like illness in 8 states.
HHS Unveils 5 New Payment Models to Transform Kidney Disease Care
July 10th 2019

HHS Unveils 5 New Payment Models to Transform Kidney Disease Care

Jaime Rosenberg
Following an executive order from President Donald Trump, HHS announced the launch of Advancing American Kidney Health, an initiative to improve the health of the 37 million Americans living with kidney disease, by releasing 5 new payment models.
Dr Jaime Davidson Outlines Unmet Needs to Improve Diabetes Care
July 10th 2019

Dr Jaime Davidson Outlines Unmet Needs to Improve Diabetes Care

Physician, patient, and caregiver education is important to improve diabetes care, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
Site Logo
July 10th 2019

Healthcare Network Analysis of Patients With Diabetes and Their Physicians

James Davis, PhD Eunjung Lim, PhD Deborah A. Taira, ScD John Chen, PhD
Network analyses of patients with diabetes in Hawaii illustrate structures and links that health plans could leverage to strengthen quality improvement and disease management programs.
Podcast: This Week in Managed Care—The Top Managed Care News From the First Half of 2019
July 7th 2019

Podcast: This Week in Managed Care—The Top Managed Care News From the First Half of 2019

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Corporate America Must Address Employee Chronic Conditions to Help Achieve the Triple Aim
July 5th 2019

Corporate America Must Address Employee Chronic Conditions to Help Achieve the Triple Aim

Dr. Gary Mangiofico
The Triple Aim will be within reach when there is greater stakeholder engagement and systemic ownership. A good start is for more employers to provide more American workers with access to high-quality wellness programs that can impact chronic disease with population health strategies.
This Week in Managed Care: July 5, 2019
July 5th 2019

This Week in Managed Care: July 5, 2019

This week, we recap the top managed care news from the first half of 2019, including outcomes from some of the biggest diabetes trials, research into the annual Medicare wellness visit, and an experimental treatment in Parkinson disease.
Dr Jaime Davidson Discusses Challenges of Access for Patients With Diabetes
July 1st 2019

Dr Jaime Davidson Discusses Challenges of Access for Patients With Diabetes

With more than 30 million patients with diabetes and only 6000 endocrinologists, that primary care doctor is playing a crucial role in seeing diabetics, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
<1
...
181920212223242526
...
99>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo